Dow Down 0.02% Nasdaq Up 0.07%

BioCryst Pharmaceuticals, Inc. (BCRX)

-NasdaqGS
11.16 Up 0.54(5.08%) Nov 25, 4:00PM EST
|After Hours : 11.15 Down 0.01 (0.09%) Nov 25, 7:59PM EST
Prev Close:10.62
Open:10.65
Bid:9.01 x 100
Ask:N/A
1y Target Est:17.73
Beta:5.1
Next Earnings Date:18-Feb-15BCRX Earnings announcement
Day's Range:10.62 - 11.21
52wk Range:5.63 - 14.62
Volume:1,090,458
Avg Vol (3m):1,223,870
Market Cap:801.99M
P/E (ttm):N/A
EPS (ttm):-0.61
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BCRXUp 5.08%801.99M
GSKUp 0.02%111.26B
RHHBYDown 0.37%252.84B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):40.75
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.74
Quarterly EPS Est (Dec-14) :-0.22
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):-1.94

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule pharmaceuticals that block key enzymes involved in the pathogenesis of diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback